Global Neuraminidase Inhibitor Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Table of Contents

1 Market Overview
    1.1 Neuraminidase Inhibitor Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Neuraminidase Inhibitor Revenue by Type: 2019 Versus 2021 Versus 2026
        1.2.2 Zanamivir
        1.2.3 Oseltamivir
        1.2.4 Peramivir
        1.2.5 Laninamivir
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Neuraminidase Inhibitor Revenue by Application: 2019 Versus 2021 Versus 2026
        1.3.2 Hospital Pharmacies
        1.3.3 Drug Stores
        1.3.4 Retail Stores
        1.3.5 Others
    1.4 Global Neuraminidase Inhibitor Market Size & Forecast
        1.4.1 Global Neuraminidase Inhibitor Sales in Value (2016-2026))
        1.4.2 Global Neuraminidase Inhibitor Sales in Volume (2016-2026)
        1.4.3 Global Neuraminidase Inhibitor Price by Type (2016-2026) & (US$/Unit)
    1.5 Global Neuraminidase Inhibitor Production Capacity Analysis
        1.5.1 Global Neuraminidase Inhibitor Total Production Capacity (2016-2026)
        1.5.2 Global Neuraminidase Inhibitor Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Neuraminidase Inhibitor Market Drivers
        1.6.2 Neuraminidase Inhibitor Market Restraints
        1.6.3 Neuraminidase Inhibitor Trends Analysis
2 Manufacturers Profiles
    2.1 GlaxoSmithKline
        2.1.1 GlaxoSmithKline Details
        2.1.2 GlaxoSmithKline Major Business
        2.1.3 GlaxoSmithKline Neuraminidase Inhibitor Product and Services
        2.1.4 GlaxoSmithKline Neuraminidase Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.2 Gilead Sciences
        2.2.1 Gilead Sciences Details
        2.2.2 Gilead Sciences Major Business
        2.2.3 Gilead Sciences Neuraminidase Inhibitor Product and Services
        2.2.4 Gilead Sciences Neuraminidase Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.3 F. Hoffman-La Roche
        2.3.1 F. Hoffman-La Roche Details
        2.3.2 F. Hoffman-La Roche Major Business
        2.3.3 F. Hoffman-La Roche Neuraminidase Inhibitor Product and Services
        2.3.4 F. Hoffman-La Roche Neuraminidase Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.4 BioCryst
        2.4.1 BioCryst Details
        2.4.2 BioCryst Major Business
        2.4.3 BioCryst Neuraminidase Inhibitor Product and Services
        2.4.4 BioCryst Neuraminidase Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.5 Daiichi Sankyo
        2.5.1 Daiichi Sankyo Details
        2.5.2 Daiichi Sankyo Major Business
        2.5.3 Daiichi Sankyo Neuraminidase Inhibitor Product and Services
        2.5.4 Daiichi Sankyo Neuraminidase Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Neuraminidase Inhibitor Sales by Manufacturer
    3.1 Global Neuraminidase Inhibitor Sales in Volume by Manufacturer (2019-2021e)
    3.2 Global Neuraminidase Inhibitor Revenue by Manufacturer (2019-2021e)
    3.3 Key Manufacturer Market Position in Neuraminidase Inhibitor
    3.4 Market Concentration Rate
        3.4.1 Top 3 Neuraminidase Inhibitor Manufacturer Market Share
        3.4.2 Top 6 Neuraminidase Inhibitor Manufacturer Market Share
    3.5 Global Neuraminidase Inhibitor Production Capacity by Company
    3.6 Manufacturer by Geography: Head Office and Neuraminidase Inhibitor Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions
4 Market Analysis by Region
    4.1 Global Neuraminidase Inhibitor Market Size by Region
        4.1.1 Global Neuraminidase Inhibitor Sales in Volume by Region (2016-2026)
        4.1.2 Global Neuraminidase Inhibitor Revenue by Region (2016-2026)
    4.2 North America Neuraminidase Inhibitor Revenue (2016-2026)
    4.3 Europe Neuraminidase Inhibitor Revenue (2016-2026)
    4.4 Asia-Pacific Neuraminidase Inhibitor Revenue (2016-2026)
    4.5 South America Neuraminidase Inhibitor Revenue (2016-2026)
    4.6 Middle East and Africa Neuraminidase Inhibitor Revenue (2016-2026)
5 Market Segment by Type
    5.1 Global Neuraminidase Inhibitor Sales in Volume by Type (2016-2026)
    5.2 Global Neuraminidase Inhibitor Revenue by Type (2016-2026)
    5.3 Global Neuraminidase Inhibitor Price by Type (2016-2026)
6 Market Segment by Application
    6.1 Global Neuraminidase Inhibitor Sales in Volume by Application (2016-2026)
    6.2 Global Neuraminidase Inhibitor Revenue by Application (2016-2026)
    6.3 Global Neuraminidase Inhibitor Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
    7.1 North America Neuraminidase Inhibitor Sales by Type (2016-2026)
    7.2 North America Neuraminidase Inhibitor Sales by Application (2016-2026)
    7.3 North America Neuraminidase Inhibitor Market Size by Country
        7.3.1 North America Neuraminidase Inhibitor Sales in Volume by Country (2016-2026)
        7.3.2 North America Neuraminidase Inhibitor Revenue by Country (2016-2026)
        7.3.3 United States Market Size and Forecast (2016-2026)
        7.3.4 Canada Market Size and Forecast (2016-2026)
        7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
    8.1 Europe Neuraminidase Inhibitor Sales by Type (2016-2026)
    8.2 Europe Neuraminidase Inhibitor Sales by Application (2016-2026)
    8.3 Europe Neuraminidase Inhibitor Market Size by Country
        8.3.1 Europe Neuraminidase Inhibitor Sales in Volume by Country (2016-2026)
        8.3.2 Europe Neuraminidase Inhibitor Revenue by Country (2016-2026)
        8.3.3 Germany Market Size and Forecast (2016-2026)
        8.3.4 France Market Size and Forecast (2016-2026)
        8.3.5 United Kingdom Market Size and Forecast (2016-2026)
        8.3.6 Russia Market Size and Forecast (2016-2026)
        8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
    9.1 Asia-Pacific Neuraminidase Inhibitor Sales by Type (2016-2026)
    9.2 Asia-Pacific Neuraminidase Inhibitor Sales by Application (2016-2026)
    9.3 Asia-Pacific Neuraminidase Inhibitor Market Size by Region
        9.3.1 Asia-Pacific Neuraminidase Inhibitor Sales in Volume by Region (2016-2026)
        9.3.2 Asia-Pacific Neuraminidase Inhibitor Revenue by Region (2016-2026)
        9.3.3 China Market Size and Forecast (2016-2026)
        9.3.4 Japan Market Size and Forecast (2016-2026)
        9.3.5 Korea Market Size and Forecast (2016-2026)
        9.3.6 India Market Size and Forecast (2016-2026)
        9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
        9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
    10.1 South America Neuraminidase Inhibitor Sales by Type (2016-2026)
    10.2 South America Neuraminidase Inhibitor Sales by Application (2016-2026)
    10.3 South America Neuraminidase Inhibitor Market Size by Country
        10.3.1 South America Neuraminidase Inhibitor Sales in Volume by Country (2016-2026)
        10.3.2 South America Neuraminidase Inhibitor Revenue by Country (2016-2026)
        10.3.3 Brazil Market Size and Forecast (2016-2026)
        10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Neuraminidase Inhibitor Sales by Type (2016-2026)
    11.2 Middle East & Africa Neuraminidase Inhibitor Sales by Application (2016-2026)
    11.3 Middle East & Africa Neuraminidase Inhibitor Market Size by Country
        11.3.1 Middle East & Africa Neuraminidase Inhibitor Sales in Volume by Country (2016-2026)
        11.3.2 Middle East & Africa Neuraminidase Inhibitor Revenue by Country (2016-2026)
        11.3.3 Turkey Market Size and Forecast (2016-2026)
        11.3.4 Egypt Market Size and Forecast (2016-2026)
        11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
        11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
    12.1 Sales Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
    12.2 Neuraminidase Inhibitor Typical Distributors
    12.3 Neuraminidase Inhibitor Typical Customers
13 Research Findings and Conclusion
14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer